The end of an era of cancer drug discovery: life without new drug targets
Immuno-Oncology Insights 2022; 3(4), 189–194
Published: 11 April 2022
Armen Mardiros & Alexander Kamb A2 Biotherapeutics, Inc.
“We believe that cell therapy is the therapeutic modality best suited to overcome the present challenges in oncology.”